Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Post-marketing Study for Evaluation of Ongoing Safety and Effectiveness of Catheter Mapping and Ablation Using Commercially Approved BWI Medical Devices for the Treatment of Patients With Cardiac Arrhythmias

NCT04750798 is registered in ClinicalTrials.gov with Biosense Webster, Inc. as lead sponsor.

NCT NCT04750798
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04750798 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Post-marketing Study for Evaluation of Ongoing Safety and Effectiveness of Catheter Mapping and Ablation Using Commercially Approved BWI Medical Devices for the Treatment of Patients With Cardiac Arrhythmias
Lead sponsor
Biosense Webster, Inc.
Phase
Observational
Overall status
Recruiting
Start date
February 22, 2021
Completion date
December 31, 2037
Enrollment
8,000 (estimated)
Sites
46

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmias, cardiac